# Ovid Therapeutics (United States)

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/ovid-therapeutics-united-states/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 74 |
| Citations | 2,280 |
| City | New York |
| Country | United States |
| Description | Ovid Therapeutics (United States) is a research organisation in New York, United States. OpenAlex records 99 works and 2,280 citations for it. 1 researchers list it as their most recent affiliation. |
| Homepage | https://ovidrx.com/ |
| OpenAlex ID | https://openalex.org/I4210166081 |
| Region | New York |
| Researchers | 1 |
| ROR ID | https://ror.org/05wmdnq05 |
| Type | company |
| Works | 99 |

## University papers

- [Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trial](https://scholariq.org/papers/safety-and-tolerability-of-gene-therapy-with-an-adeno-associated-virus-aav-borne/)
- [AAV2-GAD gene therapy for advanced Parkinson's disease: a double-blind, sham-surgery controlled, randomised trial](https://scholariq.org/papers/aav2-gad-gene-therapy-for-advanced-parkinson-s-disease-a-double-blind-sham/)

## University researchers

- [Matthew J. During](https://scholariq.org/researchers/matthew-j-during/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.